CervoMed Inc.
CRVO
$9.41
-$0.025-0.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.76M | 1.92M | 2.16M | 1.94M | 3.29M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.76M | 1.92M | 2.16M | 1.94M | 3.29M |
| Cost of Revenue | 5.11M | 4.84M | 7.09M | 5.13M | 3.77M |
| Gross Profit | -3.35M | -2.92M | -4.92M | -3.19M | -483.40K |
| SG&A Expenses | 3.27M | 2.38M | 2.32M | 2.21M | 2.51M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.37M | 7.22M | 9.40M | 7.34M | 6.28M |
| Operating Income | -6.62M | -5.30M | -7.24M | -5.40M | -3.00M |
| Income Before Tax | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.26M | -4.89M | -6.71M | -4.75M | -2.32M |
| EBIT | -6.62M | -5.30M | -7.24M | -5.40M | -3.00M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.70 | -0.56 | -0.77 | -0.55 | -0.27 |
| Normalized Basic EPS | -0.44 | -0.35 | -0.48 | -0.34 | -0.17 |
| EPS Diluted | -0.70 | -0.56 | -0.77 | -0.55 | -0.27 |
| Normalized Diluted EPS | -0.44 | -0.35 | -0.48 | -0.34 | -0.17 |
| Average Basic Shares Outstanding | 8.95M | 8.70M | 8.71M | 8.70M | 8.70M |
| Average Diluted Shares Outstanding | 8.95M | 8.70M | 8.71M | 8.70M | 8.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |